T0	Outcomes 71 75	HIV:
T1	Outcomes 224 263	risk of disease severity and morbidity.
T2	Outcomes 295 314	safety and efficacy
T3	Outcomes 377 448	increased serum 25-hydroxyvitamin D (25(OH)D) and improve immune status
T4	Outcomes 638 690	Safety, 25(OH)D-related parameters and immune status
T5	Outcomes 847 863	safety concerns.
T6	Outcomes 1150 1157	25(OH)D
T7	Outcomes 1182 1228	Percentage of naive T-helper cells (Th naive%)
T8	Outcomes 1263 1284	T-helper cells (CD4%)
T9	Outcomes 1404 1418	RNA viral load
T10	Outcomes 1480 1515	in 25(OH)D predicted RNA viral load
T11	Outcomes 1535 1543	and CD4%
T12	Outcomes 1665 1683	increasing 25(OH)D
T13	Outcomes 1710 1754	some clinically important HIV immune markers